Table 2.
Distribution of the study population hormonal status according to the reference range for age and sex of each individual
| Low n (%) | Normal n (%) | High n (%) | |
|---|---|---|---|
| T3 A | 17 (42.50%) | 23 (57.50%) | 0.00 (0.00%) |
| T3 B | 14 (35.00%) | 26 (65.00%) | 0.00 (0.00%) |
| T3 C | 12 (30.00%) | 28 (70.00%) | 0.00 (0.00%) |
| T4 A | 27 (67.50%) | 12 (30.00%) | 1 (2.50%) |
| T4 B | 19 (47.50%) | 20 (50.00%) | 1 (2.50%) |
| T4 C | 16 (40.00%) | 23 (57.50%) | 1 (2.50%) |
| FT3 A | 33 (82.50%) | 7 (17.50%) | 0 (0%) |
| FT3 B | 31 (77.50%) | 9 (22.50%) | 0 (0%) |
| FT3 C | 29 (72.50%) | 11 (27.50%) | 0 (0%) |
| FT4 A | 15 (37.50%) | 23 (57.50%) | 2 (5.00%) |
| FT4 B | 5 (12.50%) | 32 (80.00%) | 3 (7.50%) |
| FT4 C | 4 (10.00%) | 32 (80.00%) | 4 (10.00%) |
| TSH A | 13 (32.50%) | 26 (65.00%) | 1 (2.50%) |
| TSH B | 10 (25.00%) | 25 (62.50%) | 5 (12.50%) |
| TSH C | 11 (27.50%) | 25 (62.50%) | 4 (10.00%) |
| rT3 A | 0 (0%) | 0 (0%) | 40 (100%) |
| rT3 C | 0 (0%) | 0 (0%) | 40 (100%) |
FT3 free triiodothyronine, FT4 free thyroxine, rT3 reverse triiodothyronine, T3 triiodothyronine, T4 thyroxine, TSH thyroid stimulating hormone, A on admission, B on shock reversal, C five days after shock reversal